
Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the recent filing of a patent application that extends the breadth of its platform from neurodegenerative to neuropsychiatric indications: “Treatment of mental illness via …
Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap Read More